The Cancer Survivors Network (CSN) is a peer support community for cancer patients, survivors, caregivers, families, and friends! CSN is a safe place to connect with others who share your interests and experiences.

Thank you for being a part of the Cancer Survivor Network community. Survivors and caregivers like you have played a unique role in fostering an online environment that encourages connection among those needing support, community, and education. On May 28, the Network will be discontinued. More details are available here . If you have any questions, contact CSNSupportTeam@cancer.org. Thanks again for the support you’ve provided each other over the years. We remain committed to supporting you in other ways throughout your cancer journey.

clinical trial with everolimus

marcus32
marcus32 CSN Member Posts: 6
edited March 2014 in Prostate Cancer #1
I am about to join a clinical trial on a drug called everolimus (rad001). It is a drug now given to advanced renal cell cancer patients. It is hoped that it will slow the progression of prostate cancer. Is anyone out there familar with this drug and the possible side effects.
Like Care

Comments

  • William Parkinson
    William Parkinson CSN Member Posts: 60 Member
    #2
    Everolimus
    I am curious about how you have faired since going on Everolimus. This drug is a so-called rapalog; that is, it is derived from rapamycin (=sirolimus). Rapamycin is a potent immunesuppressor used for renal allograft transplantation, but it is also a powerful antiproliferative drug. It can pack a powerful punch to both androgen-independant Pca and androgen-dependant Pca. So I sm curious how the trail is going. Thx for any info and good luck!
    Like Care

Discussion Boards